MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera Depreciation & Amortization 2011-2026 | NTRA
Annual Depreciation & Amortization Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.7 M | 11.3 M | 8.61 M | 7.73 M | 7.5 M | 7.14 M | 6.18 M | 5.54 M | 5.15 M | 2.53 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.7 M | 2.53 M | 7.83 M |
Quarterly Depreciation & Amortization Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 3 M | - | - | - | 2.55 M | - | 6.22 M | 4.04 M | 1.83 M | - | 5.92 M | 3.95 M | 1.92 M | - | 5.57 M | 3.68 M | 1.86 M | - | 5.32 M | 3.62 M | 1.76 M | - | 4.18 M | 2.43 M | 1.19 M | - | 4.36 M | 2.97 M | 1.64 M | - | 3.67 M | 2.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.22 M | 1.19 M | 3.36 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Danaher Corporation
DHR
|
721 M | $ 237.64 | 1.12 % | $ 174 B | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 12.15 | -5.81 % | $ 345 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 23.25 | -0.66 % | $ 250 M |  China |
 |
DexCom
DXCM
|
186 M | $ 66.95 | -2.16 % | $ 25.8 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.59 | -0.94 % | $ 2.02 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 6.12 | - | $ 180 M | USA |
 |
IQVIA Holdings
IQV
|
1.11 B | $ 243.33 | 0.06 % | $ 44.1 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 39.59 | -0.76 % | $ 1.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 17.02 | -1.16 % | $ 915 M | USA |
 |
Celcuity
CELC
|
130 K | $ 107.43 | 2.63 % | $ 4.24 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
11.5 M | $ 1.95 | -4.66 % | $ 495 M | USA |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 3.41 | -0.29 % | $ 109 K | USA |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 102.13 | 0.34 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 27.84 | -0.2 % | $ 842 M | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | $ 48.32 | -0.27 % | $ 10.8 B |  Niderland |
 |
RadNet
RDNT
|
138 M | $ 77.42 | -1.22 % | $ 5.65 B | USA |
 |
Guardant Health
GH
|
42.4 M | $ 110.18 | 1.32 % | $ 13.5 B | USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
354 M | $ 141.01 | -3.31 % | $ 22.4 B | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 220.64 | 2.38 % | $ 11.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.16 B | $ 620.69 | 2.34 % | $ 237 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 35.58 | 2.42 % | $ 2.13 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 175.1 | -1.49 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 5.46 | -2.15 % | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 252.61 | -0.81 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 183.13 | -2.7 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
130 M | $ 715.47 | 0.43 % | $ 59 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 67.98 | 0.19 % | $ 4.7 B | USA |
 |
Agilent Technologies
A
|
321 M | $ 148.92 | 2.17 % | $ 45.3 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.75 | -4.84 % | $ 6.32 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 8.02 | 0.25 % | $ 502 M | USA |